Louis-Marie Bachelot

Louis-Marie Bachelot is a seasoned professional in the biotechnology sector with extensive experience in leadership and project management. Currently serving as Secretary at Atlanpole Biotherapies and as a Board Member at ANGERS TECHNOPOLE, Louis-Marie also holds the position of CEO at GlioCure, a company focused on developing treatments for glioblastoma. Previous roles include Project Holder at France Biotech and Freelance Consultant at Louis-Marie Bachelot Conseil en Biotechnologie, where responsibilities encompassed managing preclinical and clinical projects. As a co-founder and Head of Finance at Sisene, Louis-Marie contributed to preclinical ophthalmological developments. An academic background includes a Master's degree in Biochemistry and Molecular Biology from King's College London, a Master's in Business and Finance from Sciences Po, and a Bachelor's in History from Université catholique de l'Ouest.